Atorvastatin to Reduce Cisplatin-Induced Hearing Loss Among Individuals With Head and Neck Cancer

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(5 sites)

United States

Winship Cancer Institute at Emory University, Atlanta, Georgia

University of Maryland Medical Center, Baltimore, Maryland

National Institutes of Health Clinical Center, Bethesda, Maryland

Wilmot Cancer Institute at the University of Rochester Medical Center in New Yor, Rochester, New York

Inova Schar Cancer Center, Fairfax, Virginia